Grave, Erick Cruz
Loehfelm, Thomas
Corwin, Michael T.
Zepeda, Joseph
Bath, Harjot K.
Dhaliwal, Sandeep
Yazdanfar, Maryam
Bowlus, Christopher L. http://orcid.org/0000-0002-3906-6811
Article History
Received: 6 July 2023
Revised: 7 September 2023
Accepted: 8 September 2023
First Online: 13 October 2023
Declarations
:
: CLB has received grants from Boston Scientific, Calliditas Therapeutics, Cara Therapeutics, ChemoMab, COUR Pharmaceuticals, Cymabay Therapeutics, Gilead Sciences, GSK Pharmaceuticals, Hanmi Pharmaceuticals, Intercept Pharmaceuticals, Ipsen Bioscience, Mirum Pharmaceuticals, Novo Nordisk, Pliant Therapeutics, and Viking Therapeutics. CLB has been an advisor for Cymabay Therapeutics, GSK Pharmaceuticals, Invea Therapeutics, and Ipsen Bioscience. MTC is a consultant for Corcept Therapeutics.